The therapeutic significance of targeting TRPV1 for pain relief in OA and IBD has been underscored by clinical trials [66, 84], while the role of TRPV1 in RA‐related pain remains controversial [85]. The gene discussed is TRPV1; the disease is inflammatory bowel disease.